Document is current

Article History

Received: 31 October 2025

Accepted: 25 November 2025

First Online: 28 November 2025

Declarations

:

: AMV and SCD have received honoraria from Abbvie, Amgen, Biogen, Bial, Chiesi, Janssen, Kern Pharma, Lilly, Lundbeck, Merck, Novartis, Organon, Pfizer, Roche, Sanofi, Teva, UCB, and Zambon. JCL has received honoraria from Abbvie, Lundbeck, Novartis, Organon, and Teva. IFL has nothing to disclose. NGG has nothing to disclose. SSL has received honoraria as a consultant for Abbvie, Organon, Pfizer, and Teva, and as a speaker for Abbvie, Dr. Reddy’s, Eli Lilly, Lundbeck, Organon, Pfizer, and Teva. YGO has nothing to disclose. AGM has received speaker honoraria from Teva, Lilly, and Altermedica. Her salary has been partially funded by Río Hortega (CM21/00178) and Juan Rodés (JR23/00005) fellowships from Instituto de Salud Carlos III and the European Union (ESF+) She is principal investigator of a research project funded by Instituto de Salud Carlos III (PI24/01085), a board member of the Future Headache Experts (European Headache Federation), secretary of the RRFS (European Academy of Neurology), and coordinator of the junior Headache Group of the Spanish Society of Neurology. JC has nothing to disclose. LPS has nothing to disclose. LMCS has received honoraria from Lilly and Teva. SMGS has received honoraria from Lilly and Teva. AP has nothing to disclose. NMSM has received honoraria from Teva, Abbvie, Lilly, Novartis, Exeltis, Organon, Dr. Reddy’s, and Almirall. ALB has received speaker and/or clinical advisor honoraria from Novartis, Lilly, Teva, Lundbeck, Abbvie, Almirall, and Viatris. AMO has nothing to disclose. ASS has received honoraria from Lundbeck, Teva, Abbvie and Organon. ALR has received honoraria from Teva, Lundbeck, Dr. Reddy’s, Abbvie, Lilly, and Novartis. CMH has received honoraria from Abbvie, Lundbeck, Teva, Pfizer, Lilly, and Organon. AAL has received honoraria from Abbvie, Lilly-Organon, Lundbeck y TEVA. ALR has received honoraria for medical education and consulting with Abbvie, Lilly, Lundbeck, Novartis, and Teva. EC has received honoraria from Novartis, Chiesi, Lundbeck, Medscape, and Lilly. His salary has been partially funded by Río Hortega and Juan Rodés fellowships from Instituto de Salud Carlos III. He is junior editor for Cephalalgia. MTF has received honoraria as consultant or speaker for Allergan, Abbvie, Almirall, Chiesi, Eli Lilly, Novartis, Medlink, Teva, Organon and Pfizer. AA has received honoraria as consultant from Allergan-Abbvie, Novartis, Chiesi, and Medlink. PPR has received honoraria as consultant and speaker for Abbvie, Dr. Reddy’s, Eli Lilly, Lundbeck, Medscape, Novartis, Organon, Pfizer, and Teva. Her group has received research grants from Abbvie, Novartis, Teva, Instituto de Salud Carlos III, EraNet Neuron, and FEDER. She has also received clinical trial funding from Abbvie, Amgen, Biohaven, Eli Lilly, Novartis, Pfizer, and Teva. She is Honorary Secretary of the International Headache Society, associate editor for Cephalalgia and Neurología, and founder of . She holds no pharmaceutical company stock. RB has received honoraria from Abbvie, Organon, TEVA, Orion, Lundbeck, Pfizer, Abbott, Cardiva, Medtronik, Adamed, Dr. Reddy, Prim, Noema, Almirall, Exeltis, Novartis and Lilly. DGA has nothing to disclose. JDT has nothing to disclose. ALGP has participated in advisory and speaker boards for Abbvie, Dr. Reddy´s, Eli Lilly, Lundbeck, Novartis, Organon, Pfizer, and Teva. ABGV has participated in scientific speeches and advisory boards for Abbvie, Teva, Pfizer, Lundbeck, Organon, Lilly, Novartis, and Almirall. MHV has received honoraria for advisory boards and collaborations as consultant, scientific communicator, speaker, and for research support and congress travel from Abbvie-Allergan, Novartis, Lilly, Almirall, Chiesi, Eisai, Exeltis, Kern Pharma, Menarini, Teva, and Zambon. His research group has received research grants from Abbvie-Allergan and funding for clinical trials from Lilly, Novartis, and Teva.